Prevention and treatment of Nosema disease in bees
Compositions and methods for reducing susceptibility and enhancing tolerance to Nosema disease (Nosemosis) using RNA interference technology, and more particularly, prevention and treatment of Nosema infections in honeybees by feeding of Nosema -specific dsRNA.
1. A method for reducing the susceptibility of a bee or increasing the survival rate of a bee colony to a Nosema ceranae infection, the method comprising feeding a bee of the bee colony an effective amount of an isolated nucleic acid agent comprising a nucleic acid sequence of at least 19 contiguous nucleotides capable of binding through complementary base pairing to an mRNA encoding a Nosema ceranae polypeptide, wherein the Nosema ceranae polypeptide is selected from the group consisting of Nc014 and Nc017, and wherein expression of the mRNA encoding the Nosema ceranae polypeptide is downregulated, thereby reducing the susceptibility of said bee or increasing the survival rate of said bee colony to said Nosema ceranae infection.
2. The method of claim 1 , wherein said bee is a honeybee.
3. The method of claim 2 , wherein said honeybee is a forager.
4. The method of claim 2 , wherein said honeybee is a hive bee.
5. The method of claim 1 , wherein said nucleic acid agent comprises a nucleic acid sequence of at least 19 contiguous nucleotides complementary to any of the sequences as set forth in the group consisting of SEQ ID NOs: 46, 47, 58, and 59.
6. The method of claim 1 , wherein said nucleic acid agent comprises a plurality of nucleic acid sequences of at least 19 contiguous nucleotides complementary to any of the sequences as set forth in the group consisting of SEQ ID NOs: 58 and 59.
7. The method of claim 1 , wherein said feeding comprises providing a liquid bee-ingestible composition.
8. The methods of claim 1 , wherein said feeding comprises providing a solid bee-ingestible composition.
9. A method for reducing the susceptibility of a bee or increasing the Survival rate of a bee colony to a Nosema ceranae infection, the method comprising feeding a bee of the bee colony an effective amount of a nucleic acid agent comprising at least two non-contiguous nucleic acid sequences capable of binding through complementary base pairing to an mRNA encoding a Nosema ceranae polypeptide, wherein said nucleic acid sequences comprise at least one nucleic acid sequence of at least 19 contiguous nucleotides complementary to the sequence as set forth in SEQ ID NO: 59 and at least one nucleic acid sequence of at least 19 contiguous nucleotides complementary to the sequence as set forth in SEQ ID NOs: 57 or 58, and wherein expression of the mRNA encoding a Nosema ceranae polypeptide is downregulated, thereby reducing the susceptibility of said bee or increasing the survivability increasing the survival rate of said bee colony to said Nosema ceranae infection.
10. A method for reducing the susceptibility of a bee or increasing the survival rate of a bee colony to a Nosema ceranae infection, the method comprising feeding a bee of the bee colony an effective amount of a nucleic acid agent comprising at least two non-contiguous nucleic acid sequences capable of binding through complementary base pairing to an mRNA encoding a Nosema ceranae polypeptide, wherein said nucleic acid sequences comprise a plurality of nucleic acid sequences comprising at least one nucleic acid sequence of at least 19 contiguous nucleotides complementary to a sequence selected from the group consisting of SEQ ID NOs: 58 and 59, and wherein expression of the mRNA encoding a Nosema ceranae polypeptide is downregulated, thereby reducing the susceptibility of said bee or increasing the survival rate of said bee colony to said Nosema ceranae infection.
11. A method of reducing the susceptibility of a bee or increasing the survival rate of a bee colony to a Nosema ceranae infection, the method comprising feeding a bee of the bee colony an effective amount of double stranded ribonucleic nucleic acid (dsRNA), said dsRNA comprising at least one sequence complementary to at least 21 nucleotides of a Nosema ceranae -specific mRNA encoding a Nosema ceranae polypeptide, wherein the Nosema ceranae polypeptide is selected from the group consisting of Nc014 and Nc017, and wherein the dsRNA is capable of inducing degradation of said Nosema ceranae -specific mRNA.